methylprednisolone hemisuccinate has been researched along with acetaminophen in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bigler, D; Bukhave, K; Cruickshank, AM; Honnens, M; Kehlet, H; Schulze, S; Shenkin, A; Sommer, P | 1 |
Cortes, JE; Estey, EH; Giles, FJ; Halliburton, TA; Lim, JT; Mallard, SJ; Waddelow, TA | 1 |
2 trial(s) available for methylprednisolone hemisuccinate and acetaminophen
Article | Year |
---|---|
Effect of combined prednisolone, epidural analgesia, and indomethacin on the systemic response after colonic surgery.
Topics: Acetaminophen; Activities of Daily Living; Aged; Analgesia, Epidural; Body Temperature; Bupivacaine; C-Reactive Protein; Colonic Diseases; Drug Therapy, Combination; Fatigue; Female; Humans; Indomethacin; Interleukin-6; Leukocyte Count; Male; Methylprednisolone Hemisuccinate; Morphine; Nerve Block; Pain Measurement; Pain, Postoperative; Prostaglandins E; Respiratory Function Tests | 1992 |
Intravenous corticosteroids to reduce gemtuzumab ozogamicin infusion reactions.
Topics: Acetaminophen; Adult; Aminoglycosides; Analgesics, Non-Narcotic; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Atrial Fibrillation; Chills; Dyspnea; Erythema; Fever; Gemtuzumab; Hepatic Veno-Occlusive Disease; Humans; Hypertension; Hypotension; Immunotoxins; Infusions, Intravenous; Leukemia, Myeloid, Acute; Methylprednisolone Hemisuccinate; Pain; Rhabdomyolysis; Vomiting | 2003 |
1 other study(ies) available for methylprednisolone hemisuccinate and acetaminophen
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |